Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges

By van den Besselaar A.M.H.P.   Sturk A.   Reijnierse G.L.A.  

Thrombosis Research, Vol. 107, Iss. 5, 2002-09 ,pp. : 235-240

Elsevier

Access to resources Recommend Favorite

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage

By  

Case Reports in Neurology, Vol. 4, Iss. 2, 2012-08 ,pp. : 131-136

Karger

Access to resources Recommend Favorite

Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudin

By Mazoyer E.   Drouet L.   Delahousse B.   Gruel Y.   Rouyrre N.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 271-272

Elsevier

Access to resources Recommend Favorite

Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin

By Anand S.A.   Yusuf S.   Pogue J.   Ginsberg J.S.   Hirsh J.   on behalf of the Organization to Assess Strategies for Ischemic Syndromes OASIS Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 16-16

Elsevier

Access to resources Recommend Favorite

EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHECK PLUS ( R) IN VARIOUS CLINICAL SETTINGS

By Ruzicka K.   Kapiotis S.   Quehenberger P.   Handler S.   Hornykewycz S.   Michitsch A.   Huber K.   Clemens D.   Susan M.   Pabinger I.   Eichinger S.   Jilma B.   Speiser W.  

Thrombosis Research, Vol. 87, Iss. 5, 1997-09 ,pp. : 431-440

Elsevier

Access to resources Recommend Favorite